Dr. Arvind Chaudhry

Dr. Arvind Chaudhry, a visionary with over 17 years of expertise in diagnostics and research. As the CEO of Cordon Genomics, Dr. Chaudhry leads a team dedicated to revolutionizing personalized health diagnostics using cutting-edge technology.

About Cordon Genomics:

At Cordon Genomics, we understand that every minute matters in healthcare, and timely diagnosis can save lives. Our startup is at the forefront of innovation, utilizing next-generation sequencing (NGS) and machine learning technology to enhance healthcare outcomes. We specialize in providing unique and affordable NGS solutions compatible with various short reads sequencers, including Illumina, GeneMind, MGI, and Element Bioscience.

Key Offerings:

• Metagenomics:

  Cordon Genomics offers groundbreaking Metagenomics solutions with the Cordon ID 1 and ID 2 tests based on next-generation sequencing. These tests provide comprehensive insights into microbial communities, facilitating precision diagnostics.

• Reproductive Genetics::

  Our Reproductive Genetics portfolio includes Non-Invasive Prenatal Testing (NIPT), Preimplantation Genetic Testing for Aneuploidy (PGTA), and Endometrial Microbiome tests, featuring CountSeq technology for accurate and advanced reproductive health assessments.

• Bioinformatics:

  Cordon Genomics has developed a proprietary bioinformatics pipeline for the swift analysis of metagenomics data, ensuring quick and precise interpretation of complex genetic information.

• Microbiome:

  With the largest database of microorganisms from both healthy and diseased patients, our Microbiome solutions contribute to a deeper understanding of microbial interactions and their impact on health.

• Machine Learning Integration:

  Cordon Genomics takes a unique approach by integrating machine learning with human experience, providing precision diagnoses that leverage both advanced technology and the expertise of our skilled professionals.

Dr. Arvind Chaudhry's Experience:

• Current Role (May 2021 - Present): Founder and CEO at Cordon Genomics, leading the company towards innovation in personalized health diagnostics.

• Nationwide Children's Hospital (Mar 2016 - 2019): As a Postdoctoral Researcher, Dr. Chaudhry contributed significantly to virus discovery, metagenomics, and virome studies, identifying new viruses and developing serological assays.

• Columbia University in the City of New York (2014 - Mar 2016): In the role of a Postdoctoral Research Scientist at the Center for Infection and Immunity, Dr. Chaudhry played a pivotal role in developing the VirCapSeq-VERT platform, discovering human hepegivirus, and creating serological assays for viral diagnosis.

Cordon Genomics is not just a diagnostic solution provider; it's a commitment to advancing healthcare through innovation, expertise, and a passion for precision. Explore a new era in personalized health diagnostics with us.